Literature DB >> 11579713

Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature.

E Reinhold-Keller1, K de Groot, K Holl-Ulrich, A C Arlt, M Heller, A C Feller, W L Gross.   

Abstract

OBJECTIVE: Antineutrophil cytoplasmic antibodies (ANCA) directed against proteinase 3 are highly specific for Wegener's granulomatosis (WG); their sensitivity for active generalized WG is nearly 100%. There are patients, however, who fulfill both the ACR 1990 criteria and the CHC 1992 definition for WG but who remain ANCA negative. The authors report 3 young patients with biopsy-proven active generalized WG who were consistently negative for ANCA over observation times ranging from 58 to 114 months.
METHODS: ANCA titers were determined serially every 3 months. ANCA-negativity was defined by the absence of any fluorescence pattern on IFT plus the absence of any specific ELISA reactions. This included negative results for the antibody classes IgG, IgM and IgA. The sera of all patients were also tested in a capture PR3-ANCA ELISA. At 1- to 6-month intervals each patient underwent a standardized set of interdisciplinary examinations.
RESULTS: Although CNS involvement in large WG cohorts is about 10%, severe CNS manifestations were the clinical hallmark in all 3 patients. One patient suffered from both intraspinal and intracerebral disease with fatal outcome; the other 2 had meningeal manifestations that responded favorably to immunosuppressive therapy.
CONCLUSION: Severe CNS manifestations could represent a clinical hallmark of patients with generalized Wegener's granulomatosis who are consistently negative for antineutrophil cytoplasmic antibodies (ANCA).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579713

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  19 in total

1.  Wegener granulomatosis presenting with haemorragic stroke in a young adult.

Authors:  Cristina Granziera; Patrik Michel; Andrea O Rossetti; Floriana Lurati; Sitthided Reymond; Julien Bogousslavsky
Journal:  J Neurol       Date:  2005-03-22       Impact factor: 4.849

2.  Successful treatment of meningeal involvement in Wegener's granulomatosis with infliximab.

Authors:  J Hermann; P Reittner; M Scarpatetti; W Graninger
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

Review 3.  EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

Authors:  Bernhard Hellmich; Oliver Flossmann; Wolfgang L Gross; Paul Bacon; Jan Willem Cohen-Tervaert; Loic Guillevin; David Jayne; Alfred Mahr; Peter A Merkel; Heiner Raspe; David G I Scott; James Witter; Hasan Yazici; Raashid A Luqmani
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

4.  Pachymeningitis in granulomatosis with polyangiitis: case series with earlier onset in younger patients and literature review.

Authors:  Violeta Higuera-Ortiz; Abraham Reynoso; Natllely Ruiz; Rosa Delia Delgado-Hernández; Gilberto Gómez-Garza; Luis Felipe Flores-Suárez
Journal:  Clin Rheumatol       Date:  2016-12-23       Impact factor: 2.980

5.  A case of (double) ANCA-negative granulomatosis with polyangiitis (Wegener's).

Authors:  Tetsuya Kashiwagi; Naoaki Hayama; Emiko Fujita; Keiko Hara; Akiko Mii; Yukinari Masuda; Yasuhiko Iino; Akira Shimizu; Yasuo Katayama
Journal:  CEN Case Rep       Date:  2012-06-26

6.  Pregnancy complicating Wegener's granulomatosis.

Authors:  May Ching Soh; Hamish H Hart; Eileen Bass; Lucille Wilkinson
Journal:  Obstet Med       Date:  2009-05-22

Review 7.  Pituitary involvement in patients with granulomatosis with polyangiitis: case series and literature review.

Authors:  Yu Gu; Xuefeng Sun; Min Peng; Ting Zhang; Juhong Shi; Jiangfeng Mao
Journal:  Rheumatol Int       Date:  2019-06-15       Impact factor: 2.631

8.  Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis.

Authors:  Hyun Ah Choi; Mi Ji Lee; Chin-Sang Chung
Journal:  J Neurol       Date:  2017-02-20       Impact factor: 4.849

9.  ENT Wegener's granulomatosis can hide severe central nervous system involvement.

Authors:  B Tumiati; G Zuccoli; L Pavone; C Buzio
Journal:  Clin Rheumatol       Date:  2004-11-26       Impact factor: 2.980

10.  Wegener's disease presenting with occipital condyle syndrome.

Authors:  Alejandro Hornik; Federico Rodriguez-Porcel; Cagatay H Ersahin; Ruth Kadanoff; José Biller
Journal:  Front Neurol       Date:  2012-04-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.